Thursday, October 29, 2020

Stifel lifts Geron Corporation [GERN] price estimate. Who else is bullish?

Must read

Bunge Limited [BG] is -1.91% lower this YTD. Is it still time to buy?

Bunge Limited jumped around 1.35 points on Thursday, while shares priced at $56.45 at the close of the session, up 2.45%. The company...

Kennedy-Wilson Holdings Inc. [KW] stock Upgrade by Deutsche Bank analyst, price target now $22

Kennedy-Wilson Holdings Inc. stock went on an upward path that rose over 1.07% on Friday, amounting to a one-week price increase of more...

Pacific Ethanol Inc. [PEIX] moved down -15.05: Why It’s Important

Pacific Ethanol Inc. slipped around -1.1 points on Wednesday, while shares priced at $6.18 at the close of the session, down -15.05%. The...

Pitney Bowes Inc. [PBI] is 84.37% higher this YTD. Is it still time to buy?

Pitney Bowes Inc. gained 1.09% or 0.08 points to close at $7.43 with a heavy trading volume of 2637048 shares. The company report...

Geron Corporation [NASDAQ: GERN] closed the trading session at $1.68 on 09/24/20. The day’s price range saw the stock hit a low of $1.62, while the highest price level was $1.71.

The stocks have a year to date performance of 23.53 percent and weekly performance of -8.70 percent. The stock has been moved at 50.00 percent over the last six months. The stock has performed -4.55 percent around the most recent 30 days and changed -12.04 percent over the most recent 3-months.

If compared to the average trading volume of 3.06M shares, GERN reached to a volume of 2421312 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Geron Corporation [GERN]:

Stifel have made an estimate for Geron Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 03, 2020. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on November 19, 2019, representing the official price target for Geron Corporation stock. Previously, the target price had yet another raise to $4, while H.C. Wainwright analysts kept a Buy rating on GERN stock.

The Average True Range (ATR) for Geron Corporation is set at 0.14, with the Price to Sales ratio for GERN stock in the period of the last 12 months amounting to 1224.22. The Price to Book ratio for the last quarter was 1.65, with the Price to Cash per share for the same quarter was set at 0.75.

GERN stock trade performance evaluation

Geron Corporation [GERN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.70. With this latest performance, GERN shares dropped by -4.55% in over the last four-week period, additionally plugging by 50.00% over the last 6 months – not to mention a rise of 23.53% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GERN stock in for the last two-week period is set at 42.04, with the RSI for the last a single of trading hit 37.60, and the three-weeks RSI is set at 44.34 for Geron Corporation [GERN]. The present Moving Average for the last 50 days of trading for this stock 1.8047, while it was recorded at 1.7990 for the last single week of trading, and 1.5160 for the last 200 days.

Geron Corporation [GERN]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Geron Corporation [GERN] shares currently have an operating margin of -15761.96. Geron Corporation’s Net Margin is presently recorded at -14901.74.

Return on Total Capital for GERN is now -45.97, given the latest momentum, and Return on Invested Capital for the company is -43.51. Return on Equity for this stock declined to -43.82, with Return on Assets sitting at -39.08. When it comes to the capital structure of this company, Geron Corporation [GERN] has a Total Debt to Total Equity ratio set at 1.89. Additionally, GERN Total Debt to Total Capital is recorded at 1.85, with Total Debt to Total Assets ending up at 1.54. Long-Term Debt to Equity for the company is recorded at 1.63, with the Long-Term Debt to Total Capital now at 1.60.

Reflecting on the efficiency of the workforce at the company, Geron Corporation [GERN] managed to generate an average of -$1,490,174 per employee. Receivables Turnover for the company is 0.47 with a Total Asset Turnover recorded at a value of 0.00.Geron Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.50 and a Current Ratio set at 11.50.

Earnings per share (EPS) analysis for Geron Corporation [GERN] stock

With the latest financial reports released by the company, Geron Corporation posted -0.08/share EPS, while the average EPS was predicted by analysts to be reported at -0.15/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 46.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GERN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Geron Corporation go to 5.00%.

Geron Corporation [GERN]: Insider Ownership positions

There are presently around $263 million, or 54.90% of GERN stock, in the hands of institutional investors. The top three institutional holders of GERN stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 30,126,299, which is approximately New of the company’s market cap and around 0.41% of the total institutional ownership; BLACKROCK INC., holding 19,400,364 shares of the stock with an approximate value of $32.59 million in GERN stocks shares; and ECOR1 CAPITAL, LLC, currently with $32.31 million in GERN stock with ownership of nearly New of the company’s market capitalization.

Positions in Geron Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 78 institutional holders increased their position in Geron Corporation [NASDAQ:GERN] by around 97,324,875 shares. Additionally, 31 investors decreased positions by around 2,287,690 shares, while 41 investors held positions by with 56,969,832 shares. The mentioned changes placed institutional holdings at 156,582,397 shares, according to the latest SEC report filing. GERN stock had 32 new institutional investments in for a total of 82,621,073 shares, while 8 institutional investors sold positions of 440,657 shares during the same period.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Fortress Biotech Inc. [FBIO] Stock trading around $2.32 per share: What’s Next?

Fortress Biotech Inc. loss -4.73% on the last trading session, reaching $2.32 price per share at the time. The company report on October...

Vaxart Inc. [VXRT] gain 1326.53% so far this year. What now?

Vaxart Inc. plunged by -$0.44 during the normal trading session on Wednesday and reaching a high of $5.2881 during the day while it...

Market cap of ToughBuilt Industries Inc. [TBLT] reaches 26.19M – now what?

ToughBuilt Industries Inc. traded at a low on 10/28/20, posting a -5.71 loss after which it closed the day’ session at $0.68. The...

Wall Street Analyst Downgrade Catabasis Pharmaceuticals Inc. [CATB]. What else is Wall St. saying

Catabasis Pharmaceuticals Inc. price plunged by -8.33 percent to reach at -$0.13. The company report on October 27, 2020 that Catabasis Pharmaceuticals Announces...

Truist lifts PPD Inc. [PPD] price estimate. Who else is bullish?

PPD Inc. closed the trading session at $33.16 on 10/28/20. The day’s price range saw the stock hit a low of $32.15, while...